| Code | Project title | Period | Principal Investigator at the Insitute of Oncology |
| COST- |
Cancer and Work Network (CANWON): ISCH COST Action IS1211
| | Assoc. Prof. Vesna Zadnik PhD |
| - |
Implementation of the clinical pathway for dietary treatment of hospitalized patients, screening tools for dietary treatment of outpatients and guidelines for the physical activity of patients
| 2017-2019 | Nada Rotovnik Kozjek |
| - |
Cancer incidence at dravsko polje: geographical analysis of cancer incidence in the municipality of Rače-Fram and surrounding settlements
| 2018 - 2019 | Prof Vesna Zadnik PhD |
| N3-0059 |
Plasma-assisted wound treatment and topical introduction of molecules
| 1.1.2017 - 31.12.2020 | dr. Uroš Cvelbar (Jozef Stefan Institute)/acad. prof. dr. Serša Gregor (Institute of Oncology Ljubljana) |
| IP-0302 |
Lifelong Follow-Up of Survivors of Childhood and Adolescent Cancer and Related Translational Trials
| 1. 1. 2009-31. 12. 2021 | Asst. Prof. Lorna Zadravec Zaletel PhD |
| V3-1638 (C) |
Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population
| 1. 10. 2016-30. 9. 2019 | Assoc. Prof. Vesna Zadnik PhD |
| V3-1713 (B) |
Comprehensive analysis of management of urological cancer patients with an assessment of possible delays in referrals, realization of diagnostics procedures and first treatment
| 1.4.2018 - 31.03.2020 | Assoc. Prof. Vesna Zadnik PhD |
| V3-1718 |
Health risk assessment for exposures of children to low-frequency electric and magnetic (EM) fields in Slovenia
| 1.4.2018 - 31.3.2021 | Prof. Tadej Kotnik PhD, Prof. Vesna Zadnik PhD |
| V3-1720 (B) |
Analysis and estimation of requirements of human resources for cancer treatment in Slovenia
| 1.4.2018 - 31.3.2020 | Prof. Branko Zakotnik PhD |
| J2-1732 |
Computer-assisted medical image analysis for proton and radiotherapy treatment planning
| 1. 7. 2019 - 30. 6. 2022 | Prof. Tomaž Vrtovec |
| J3-1753 |
Molecular predictors of radiation treatment response in breast cancer
| 1. 7. 2019-30. 6. 2022 | Asst. Prof. Katja Goricar, Asst. Prof. Tanja Marinko |
| J3-1760 |
The role of imaging and laboratory markers in the evaluation of nature and growth of thyroid nodules
| 1. 7. 2019-30. 6. 2022 | Prof. Katja Zaletel / Prof. Nikola Besic |
| BI-AT-18-19-003 |
Cancer stem cell (CSC)-associated exosomes as regulators of tumor radiation response
| 1.1.2018 - 31.12.2019 | prof. dr. Maja Čemažar |
| Z3-1871 |
Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer
| 1.7.2019 - 30.6.2021 | dr. Maša Bošnjak |
| V3-1906 |
Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022
| 1. 11. 2019-30. 4. 2023 | Prof. Nikola Besic |
| V3-1907 |
Development of indicators and methodology for monitoring the late effects of cancer treatment in childhood at national level
| 1. 11. 2019-31. 10. 2021 | Assoc. Prof. Vesna Zadnik |
| V3-1911 |
Slovenian genome project
| 1. 11. 2019 – 31. 10. 2022 | Assoc. Prof. Borut Peterlin |
| V3-2032 |
The impact of COVID-19 on the cancer management in Slovenia
| 1. 10. 2020-30. 9. 2022 | Tina Žagar PhD |
| J3-2524 |
Minimally invasive diagnostic approaches in brain tumours using circulating cell-free nucleic acids
| 1. 9. 2020-31. 8. 2023 | Assoc. Prof. Jože Pižem |
| J3-2527 |
New approaches for prediction of cardiotoxicity in breast cancer radiotherapy
| 1. 9. 2020-31. 8. 2023 | Assist. Prof. Tanja Marinko |
| J3-2528 |
Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors
| 1.9.2020 - 31.8.2023 | prof. dr. Maja Čemažar |
| J3-2529 |
Role of endothelium in tumor response to radiotherapy
| 1.9.2020 - 31.8.2023 | dr. Boštjan Markelc |
| J4-2546 |
Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours
| 1.9.2020 - 31.8.2023 | prof. dr. Nataša Tozon (Veterinary Faculty)/prof. dr. Maja Čemažar (Institute of Oncology Ljubljana) |
| J4-2594 |
The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity
| 1.9.2020 - 31.8.2023 | prof. dr. Mateja Erdani Kreft (Faculty of Medicine)/ prof. dr. Maja Čemažar (Institute of Oncology Ljubljana) |
| L3-2622 |
Biological markers of development, progression and treatment response in asbestos related diseases
| 1. 9. 2020-31. 8. 2023 | Assoc. Prof. Vita Dolžan, Prof. Viljem Kovac |
| Z3-2651 |
Electrochemotherapy as in situ vaccination therapy
| 1. 9. 2020 - 31. 8. 2023 | dr. Katja Uršič Valentinuzzi |
| J3-7272 (A) |
Methods of estimation of key indicators in population cancer survival
| 1.1.2016 - 31.12.2018 | prof. dr. Pohar Perme Maja (Univerza v Ljubljani, Medicinska fakulteta), prof. dr. Vesna Zadnik (Onkološki inštitut) |
| J3-7372 |
Molecular biomarkers and biomarker-driven therapy in lung cancer
| 2016-2018 | Prof. Tanja Čufer, Assoc. Prof. Viljem Kovač |
| J3-7460 |
Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model
| 1.1.2016 - 31.12.2018 | prof. dr. Strojan Primož/Institute of Oncology Ljubljana |
| J3-7494 |
Tunneling nanotubes for innovative urinary bladder cancer treatment
| 2016-2018 | Prof. Maja Cemazar PhD |
| L2-7550 |
Electrospun nanofibrous materials for solid state drug delivery system
| 1.3.2016 - 28.2.2019 | prof. dr. Igor Emri /acad. prof. dr. Gregor Serša (Institute of Oncology Ljubljana) |
| J1-8140 |
Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard
| 1.5.2017 - 30.4.2021 | prof. dr. Filipič Metka (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana) |
| J3-8202 |
Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and interleukin-12 gene therapy boost
| 1.5.2017 - 30.4.2021 | prof. dr. Maja Čemažar |
| L3-8203 |
Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases
| 1. 5. 2017-30. 6. 2020 | Assoc. Prof. Viljem Kovač |
| Z3-8204 |
Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect
| 1.4.2018 - 31.3.2020 | dr. Tanja Jesenko |
| J3-8210 |
Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention
| 2017-2020 | Sr. Res. Fell. Srdjan Novaković |
| J4-8227 |
Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy
| 1.5.2017 - 30.4.2020 | prof. dr. Kos Janko (Univerza v Ljubljani, Fakulteta za farmacijo/IJS)/ acad. prof. dr. Gregor Serša (Onkološki inštitut) |
| J2-9225 |
Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields
| 1.7.2018 - 30.6.2021 | prof. dr. Damijan Miklavčič (Faculty of Electrical Engineering/ acad. prof. dr. Gregor Serša Institute of Oncology Ljubljana |
| J3-9269 |
Clinical pharmacological approach to optimization of therapeutic concentration of bleomycin treatment with electrochemotherapy
| 1.7.2018 - 30.6.2021 | acad. prof. dr. Serša Gregor |
| J5-9336 |
Opportunities and dangers of online health communities for healthcare
| 2018-2022 | Asst. Prof. Rok Petrič |
